Showing results (11-20 of 156) with videos related to
Sort By:
Pageof 16
Drugs|January 30, 2023
Mitigating Serious Adverse Events in Gene Therapy with AAV Vectors: Vector Dose and ImmunosuppressionHildegund C J ErtlMolecular Therapy : the Journal of the American Society of Gene Therapy|September 29, 2004
Adenoviruses as vaccine vectorsNia Tatsis, Hildegund C J ErtlCancer Research|July 10, 2021
PPARα Agonist Fenofibrate Enhances Cancer Vaccine EfficacyArezki Chekaoui, Hildegund C J ErtlOncotarget|March 5, 2016
Depletion of FAP+ cells reduces immunosuppressive cells and improves metabolism and functions CD8+T cells within tumorsYing Zhang, Hildegund C J ErtlExpert Opinion on Biological Therapy|December 24, 2005
Therapeutic potential of adenovirus as a vaccine vector for chronic virus infectionsDongming Zhou, Hildegund C J ErtlFrontiers in Immunology|February 24, 2016
Starved and Asphyxiated: How Can CD8(+) T Cells within a Tumor Microenvironment Prevent Tumor ProgressionYing Zhang, Hildegund C J ErtlFrontiers in Microbiology|August 3, 2011
Can Viruses be Modified to Achieve Sustained Gene TransferHua Li, Hildegund C J ErtlCurrent Gene Therapy|April 28, 2005
Adenoviral gene delivery for HIV-1 vaccinationT Vanniasinkam, H C J ErtlCurrent Opinion in Immunology|June 1, 2010
Current Opinion in Immunology. Vaccines. IntroductionHildegund C J Ertl, Antonio LanzavecchiaPageof 16